Back to search

Article

A Randomized Placebo Controlled Clinical Trial of a Metabolic Shifting Probiotic, Sugar Shift, for the Treatment of T2DM

2022-12-07

Abstract excerpt

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia, insulin resistance and chronic inflammation. Probiotics have been claimed effective in the management of obesity and type 2 diabetes mellitus. BiotiQuest™ Sugar Shift is a symbiotic formulation rationally designed for the endogenous conversion of glucose and fructose to support restoration of the human gut microbiota, m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
41b14a49-5ffd-50da-870a-5c6d827c2e43
DOI
10.1101/2022.12.06.22283186
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Randomized Placebo Controlled Clinical Trial of a Metabolic Shifting Probiotic, Sugar Shift, for the Treatment of T2DMDOI 10.1101/2022.12.06.22283186
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectivenessSemantic proximity
Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulationSemantic proximity
Therapeutic Potential of Butyrate for Treatment of Type 2 DiabetesSemantic proximity
Microbiota based personalized nutrition improves hyperglycaemia and hypertension parameters and reduces inflammation: A prospective, open label, controlled, randomized, comparative, proof of concept studySemantic proximity
Cross-feeding-based rational design of a probiotic combination of Bacterides xylanisolvens and Clostridium butyricum therapy for metabolic diseasesSemantic proximity
Dietary carbohydrates alter immune-modulatory functionalities and DNA inversions in Bacteroides thetaiotaomicronSemantic proximity
Modulation of the Gut Microbiome by Novel Synthetic Glycans for the Production of Propionate and the Reduction of Cardiometabolic Risk FactorsSemantic proximity
In Search of Healthy Ageing: A Microbiome-Based Precision Nutrition Approach for Type 2 Diabetes PreventionSemantic proximity
Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patientsSemantic proximity
Effect of Sodium Butyrate Supplementation on Type 2 Diabetes—Literature ReviewSemantic proximity
Some current applications, limitations and future perspectives of lactic acid bacteria as probioticsSemantic proximity
Effect of functional food ingredients on gut microbiota in a rodent diabetes modelSemantic proximity
Select a neighboring publication to make it the new centre.